Company Quick10K Filing
Waters
10-Q 2020-06-27 Filed 2020-07-29
10-Q 2020-03-28 Filed 2020-04-29
10-K 2019-12-31 Filed 2020-02-25
10-Q 2019-09-28 Filed 2019-10-30
10-Q 2019-06-29 Filed 2019-07-31
10-Q 2019-03-30 Filed 2019-05-03
10-K 2018-12-31 Filed 2019-02-26
10-Q 2018-09-29 Filed 2018-11-02
10-Q 2018-06-30 Filed 2018-08-03
10-Q 2018-03-31 Filed 2018-05-04
10-K 2017-12-31 Filed 2018-02-27
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-07-01 Filed 2017-08-04
10-Q 2017-04-01 Filed 2017-05-05
10-K 2016-12-31 Filed 2017-02-24
10-Q 2016-10-01 Filed 2016-11-04
10-Q 2016-07-02 Filed 2016-08-05
10-Q 2016-04-02 Filed 2016-05-06
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-10-03 Filed 2015-11-06
10-Q 2015-07-04 Filed 2015-08-07
10-Q 2015-04-04 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-27 Filed 2014-10-31
10-Q 2014-06-28 Filed 2014-08-01
10-Q 2014-03-29 Filed 2014-05-02
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-28 Filed 2013-11-01
10-Q 2013-06-29 Filed 2013-08-01
10-Q 2013-03-30 Filed 2013-05-03
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-29 Filed 2012-11-02
10-Q 2012-06-30 Filed 2012-08-03
10-Q 2012-03-31 Filed 2012-05-04
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-10-01 Filed 2011-11-04
10-Q 2011-07-02 Filed 2011-08-05
10-Q 2011-04-02 Filed 2011-05-06
10-Q 2010-10-02 Filed 2010-11-05
10-Q 2010-07-03 Filed 2010-08-06
10-Q 2010-04-03 Filed 2010-05-07
10-K 2009-12-31 Filed 2010-02-26
8-K 2020-08-17 Officers
8-K 2020-07-28 Earnings, Exhibits
8-K 2020-07-14 Earnings, Officers, Regulation FD, Exhibits
8-K 2020-06-17
8-K 2020-05-12
8-K 2020-04-28
8-K 2020-02-17
8-K 2020-02-04
8-K 2019-10-29
8-K 2019-09-12
8-K 2019-07-30
8-K 2019-05-14
8-K 2019-04-23
8-K 2019-01-23
8-K 2018-10-23
8-K 2018-09-01
8-K 2018-07-24
8-K 2018-05-09
8-K 2018-05-09
8-K 2018-04-24
8-K 2018-01-23

Waters Financials

WAT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Illumina (ILMN) 44,722 69% 35.1 14% 7,089 2,650 3,458 2,395 973 1,255 44,038
Agilent Technologies (A) 24,292 54% 18.0 9% 9,452 4,704 5,163 2,805 877 1,368 24,690
Mettler Toledo (MTD) 17,554 58% 26.5 21% 2,636 2,198 2,983 1,720 550 700 18,558
Waters (WAT) 15,473 18% 31.8 15% 2,561 2,446 2,405 428 392 513 16,324
Bio-Rad Laboratories (BIO) 10,341 55% 12.0 5% 7,177 2,046 2,304 1,259 377 850 10,215
PerkinElmer (PKI) 9,500 48% 25.3 4% 6,489 3,782 2,835 1,374 234 449 11,362
Bruker (BRKR) 6,836 48% 23.2 9% 2,352 1,507 2,026 972 207 305 7,055
Coherent (COHR) 3,296 34% 37.6 3% 2,083 798 1,431 486 54 79 2,977
Accelerate Diagnostics (AXDX) 1,034 45% -15.4 -58% 147 137 8 3 -85 -72 1,112
Pacific Biosciences of California (PACB) 862 33% -7.4 -79% 146 95 82 27 -115 -113 840
Fluidigm (FLDM) 852 40% -16.2 -19% 269 107 117 46 -52 -51 824
Quanterix (QTRX) 607 39% -12.8 -22% 176 39 52 20 -39 -39 501
EyePoint Pharmaceuticals (EYPT) 194 67% -2.9 -101% 79 63 12 8 -80 -72 209
Harvard Bioscience (HBIO) 130 55% 33.8 -1% 163 86 119 66 -2 5 175
HTG Molecular Diagnostics (HTGM) 36 48% 0.2 -29% 51 23 14 7 -15 -13 -2
Precipio (PRPO) 20 4% -2.2 -42% 23 7 6 0 -9 -9 19
Astrotech (ASTC) 11 17% -1.4 -144% 5 4 0 0 -7 -7 10
Bionano Genomics (BNGO) 7 29% 0.1 -81% 19 27 11 3 -16 -13 -1
Aethlon Medical (AEMD) 0 0% 0.1 -579% 1 1 0 0 -7 -7 -0

Balance Sheet ($MM)2009-12-312010-04-032010-07-032010-10-022010-12-312011-04-022011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-312013-03-302013-06-292013-09-282013-12-312014-03-292014-06-282014-09-272014-12-312015-04-042015-07-042015-10-032015-12-312016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-312018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Cash3412973112633082973451,1301,2811,3071,3921,4481,5391,5901,6501,6991,8041,8531,9181,9462,0552,1092,2092,3112,3992,5052,6002,6002,8132,9663,1263,2553,3942,5522,2482,0841,7351,167676405
Accounts Receivable314314314338358349365354367354355362405377365374431401402393434394407416468440446446489462463456534503493489568508519505
Inventory179189192208204224243246213233237247230236243257243267273269246258273282263287286286263280287298270300300314292333352369
PP&E211209211215466217219221518239251261587283296314659330329323685317325326705337330330769334339343838349336338872356369381
Assets1,9081,9812,0362,2062,3282,4472,5722,6402,7232,8392,8842,9973,1683,2073,2863,4253,5833,6503,7283,7523,8783,8734,0294,1214,2694,3684,4484,4484,6624,8114,9975,1635,3244,4894,1584,0433,7273,2502,8232,561
Accounts Payable50585963646768645561636055605663657365606664656271736666686771676571716668726765
Long-Term Debt5007007007007004007007007007007007001,0451,1001,1351,1601,1901,1001,1601,2051,2401,3101,3851,4551,4931,5931,6321,6321,8301,6421,6871,7322,0001,2481,1481,1481,1501,0481,0481,256
Liabilities1,0591,1681,2231,2821,2591,2961,3461,4811,4971,5521,6211,6671,7011,7311,7651,8071,8191,8301,8841,9101,9832,0102,0962,1532,2102,2672,2992,2992,3602,4162,4782,5343,0912,3752,1832,1672,1602,2822,2672,446
Stockholders' Equity8139231,0691,1511,2261,1591,2271,2881,2631,3301,4671,4761,5201,6191,7631,8191,8431,8421,8951,8621,9331,9692,0592,1022,1492,1492,3022,3952,5192,6292,2342,1151,9751,8761,567968556116
Income Statement ($MM)2009-12-312010-04-032010-07-032010-10-022010-12-312011-04-022011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-312013-03-302013-06-292013-09-282013-12-312014-03-292014-06-282014-09-272014-12-312015-04-042015-07-042015-10-032015-12-312016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-312018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Revenue368391401484428448455521420451450522430451457565431482493584460495501587475537537629498558566687531596578715514599577
Cost of Revenue14615516318917017618020416717918320817518819222918820220223318920920723820122022025278828027081287
Gross Profit222236238294258272274317253272267313256263266336243280291351271286294349274316316377420477485417450428
R&D202121232225232423242425252524272527272929313128293333333133343534363538353634
SG&A107107111121117131121126117123115122119126121131127132122132120123125129129130130130131130135149130137127143134133126
Tax151761818282022161717-23-18151528121618131718132413171728816185792919281382727
Net Income76141109144138
Cash Flow ($MM)2009-12-312010-04-032010-07-032010-10-022010-12-312011-04-022011-07-022011-10-012011-12-312012-03-312012-06-302012-09-292012-12-312013-03-302013-06-292013-09-282013-12-312014-03-292014-06-282014-09-272014-12-312015-04-042015-07-042015-10-032015-12-312016-04-022016-07-022016-10-012016-12-312017-04-012017-07-012017-09-302017-12-312018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Cash Operating10311210913412397127150111105101132128109105143116128162155113139154160157157174177154192176146176127148
Cash Investing-116-59-157-79-121-53-21-161-63-128-1082-90-108-131-135-120-149-80-56-208-30-105-198-70-70-97-197-110-1328965143435140
Cash Financing-18-22-19-1-273-13-22-12-25-17-13-35-18-9-3-40-39-2-6012-9-12-37-28-28-12-10-17-24-1,006-256-723-572-367